Showing results (151-160 of 2,104) with videos related to
Sort By:
Pageof 211
Melanoma Management|December 7, 2019
Topical and intralesional therapies for in-transitmelanomaMichael A HendersonCNS Spectrums|August 30, 2012
The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimagingTheodore A HendersonAdvances in Experimental Medicine and Biology|August 8, 2024
COVID-19-Related Multi-systemic Inflammatory Syndrome in Children (MIS-C)Lauren A HendersonInternational Journal of Immunopharmacology|January 1, 1988
Large scale production and purification of paraquat and desipramine monoclonal antibodies and their Fab fragmentsM Bowles, S C Johnston, D D Schoof, et al.Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1988
Clinical applicability of current pharmacokinetic models: splanchnic elimination of 5-fluorouracil in cancer patientsP J Robinson, L Bass, S M Pond, et al.Journal of Clinical Psychopharmacology|October 1, 1992
Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophreniaH A Whiteford, T J Stedman, J Welham, et al.Therapeutic Drug Monitoring|October 1, 1994
Comparison of high-performance liquid chromatography and monoclonal fluorescence polarization immunoassay for the determination of whole-blood cyclosporin A in liver and heart transplant patientsP J Taylor, P Salm, R L Norris, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1982
A technique to study hepatic and intestinal drug metabolism separately in the dogD J Effeney, S M Pond, M W Lo, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1985
Altered methadone pharmacokinetics in methadone-maintained pregnant womenS M Pond, M J Kreek, T G Tong, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1988
Pharmacokinetics and toxicity of high doses of antibody Fab fragments in ratsP R Pentel, D E Keyler, D G Gilbertson, et al.Pageof 211